二甲双胍联合瑞格列奈治疗社区2型糖尿病患者的效果分析

目的分析二甲双胍联合瑞格列奈治疗社区2型糖尿病患者的效果。方法按照该院收治的100例患者先后顺序,将其划分为两组。2018年1—6月收治的50例纳入对照组,采取常规护理+二甲双胍干预;2018年7月—2019年1月收治的50例纳入观察组,在对照组的基础上,加入瑞格列奈治疗。对两组患者的血糖控制状况与不良反应发生状况进行统计与比较。结果两组患者干预前的血糖指标比较,差异无统计学意义(P>0.05);在干预后,观察组患者的血糖指标改善状况明显优于对照组,差异有统计学意义(P<0.05)。两组患者的不良反应发生状况比较,差异无统计学意义(P>0.05)。结论二甲双胍联合瑞格列奈治疗社区2型糖尿病患者的临床效果较好,能够对其血糖进行有效控制,降低并发症的发生,且不良反应发生率较低,值得临床推广。

Effect of Metformin Combined with Repaglinide in the Treatment of Type 2 Diabetes in the Community

Objective To analyze the effect of metformin combined with repaglinide in the treatment of type 2 diabetes in the community.Methods According to the order of 100 patients admitted to the hospital,they were divided into 2 groups.50 patients admitted to the control group from January to June 2018 were enrolled in the control group with routine nursing+metformin intervention;50 patients admitted from July 2018 to January 2019 were included in the observation group,and on the basis of the control group,added repaglinide treatment.The blood glucose control status and adverse reaction occurrence status of the two groups of patients were counted and compared.Results There was no statistically significant difference in the blood glucose index between the two groups before intervention(P>0.05).After the intervention,the improvement of blood glucose index in the observation group was significantly better than that in the control group,the difference was statistically significant(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Metformin combined with repaglinide has a good clinical effect in the treatment of type 2 diabetes in the community.It can effectively control its blood glucose,reduce the incidence of complications,and the incidence of adverse reactions is low,which is worthy of clinical promotion.